Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.
Also called NCT06825182
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,000 participants
- Registry
-
NCT06825182
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06825182. Allocation not applicable; no masking; primary purpose treatment. Start 2024-11-07 (actual); primary completion 2025-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Outpatient newly diagnosed type 2 diabetes subjects
- Intervention (Drug)
- Inpatient newly diagnosed type 2 diabetes subjects
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
Record details
- Record id
cardio:ct-nct06825182- Content hash
1d07eec7267595c4e5f8a0b4255c6530180df5c294997f057d6b08a01b6af4a4